- Abafungin
-
- $36.00
-
2026-06-02
- CAS:129639-79-8
- Purity: 98.11%
- Supply Ability: 10g
|
| | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine Basic information |
| Product Name: | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine | | Synonyms: | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine;BAY-W 6341;4-(2-(2,4-dimethylphenoxy)phenyl)-N-(1,4,5,6-tetrahydropyrimidin-2-yl)thiazol-2-amine;N-[4-[2-(2,4-Dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine;2-Pyrimidinamine, N-[4-[2-(2,4-dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-;UNII-11DI31LWXF;inhibit,Fungal,Abafungin,Inhibitor;4-(2-(2,4-dimethylphenoxy)phenyl)-N-(1,4,5,6-tetrahydropyrimidine-2-yl)thiazole-2-amine | | CAS: | 129639-79-8 | | MF: | C21H22N4OS | | MW: | 378.49 | | EINECS: | | | Product Categories: | | | Mol File: | 129639-79-8.mol | ![N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine Structure](CAS/GIF/129639-79-8.gif) |
| | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine Chemical Properties |
| Melting point | 199 °C | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | solubility | DMF: 10 mg/mL; DMSO: 2.5 mg/mL; Ethanol: 0.3 mg/mL; PBS (pH 7.2): 0.3 mg/mL | | form | powder to crystal | | color | White to Light yellow | | InChI | InChI=1S/C21H22N4OS/c1-14-8-9-18(15(2)12-14)26-19-7-4-3-6-16(19)17-13-27-21(24-17)25-20-22-10-5-11-23-20/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H2,22,23,24,25) | | InChIKey | TYBHXIFFPVFXQW-UHFFFAOYSA-N | | SMILES | C1(NC2=NC(C3=CC=CC=C3OC3=CC=C(C)C=C3C)=CS2)NCCCN=1 |
| | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine Usage And Synthesis |
| Originator | Abafungin,York Pharma | | Uses | Abafungin is a broad-spectrum antifungal agent. | | Definition | ChEBI: A member of the class of guanidines that is tetrahydropyrimidin-2(1H)-imine in which the hydrogen of the imino group is replaced by a thiazol-2-yl group which in turn is substituted by a 2-(2,4-dimethylphenoxy)phenyl group at position 4
It has been used for the topical treatment of fungal nail infections. | | Manufacturing Process | 15.8 g (0.12 mole) N-(1,4,5,6-tetrahydropyrimidinyl)thiourea were added to
27.45 g (0.1 mole) 2-(2,4-dimethylphenoxy)phenacyl chloride in 100 ml
acetone and heated to reflux for 2 hours. On cooling the falling out product
was filtered off, washed with acetone and dried. N-[4-[2-(2,4-
Dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine
hydrochloride was prepared. Yield 91.4%; MP: 160°C.
20.72 g (0.05 mole) above product was stirred with 300 ml 1 N sodium
hydroxide for 30 minutes at room temperature. The insoluble product was
filtered off, washed and dried. Yield of N-[4-[2-(2,4-dimethylphenoxy)phenyl]-
2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine was 16.2 g (86%). MP:
191°-192°C. | | Therapeutic Function | Antibacterial, Antifungal |
| | N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine Preparation Products And Raw materials |
|